MedTrace Logo

Brown Seaweed Extract on Glycemic Control and Body Weight

NCT03075943 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2022-08-16

No results posted yet for this study

Summary

The overall goal of this study is to investigate the effects of a daily dietary supplement of brown seaweed (2 capsules of InSea2®) on body weight, glycemic control and insulin secretion in overweight prediabetic men and women in association with a moderate weight loss intervention.

Conditions

Interventions

DIETARY_SUPPLEMENT

InSea2

Daily supplement: 2 capsules of InSea2

DIETARY_SUPPLEMENT

Placebo

Daily supplement: 2 capsules of Placebo

Sponsors & Collaborators

  • Ministry of Agriculture, Fisheries and Food, Quebec

    collaborator OTHER_GOV

  • innoVactiv Inc.

    collaborator INDUSTRY

  • Laval University

    lead OTHER

Principal Investigators

  • Hélène Jacques, PhD · Institue of Nutrition and Functional Food (INAF), Laval University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2018-07-31
Completion
2019-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03075943 on ClinicalTrials.gov